Comparison between insulin aspart and soluble human insulin in type 1 diabetes (IDDM) patients treated with basal-bolus insulin therapy - Phase III clinical trial in Japan

Journal of the Japan Diabetes Society

Volumn 44, Issue 10, 2001, Pages 799-811

  Iwamoto, Y ^a   Akanuma, Y ^a   Niimi, H ^a   Sasaki, N ^a   Tajima, N ^a   Kawamori, R ^a   Shigeta, Y ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ASPART;

ADULT; ARTICLE; BOLUS INJECTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; JAPAN; MAJOR CLINICAL STUDY; MALE;

EID: 0035185764     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. The effect of intensive treatment of diabetes on the development and the progression of long-term complications in insulin-dependent diabetes mellitus
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
3. Hyperglycemia and Microvascular and Macrovascular Disease in Diabetes
4. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
5. Consensus guidelines for the management of insulin-dependent (type 1) diabetes
6. Hypoglycemia in the diabetes control and complications trial
7. The effects of improved glycaemic control on complications in type 2 diabetes
8. Absorption of injected insulin
9. Insulin pharmacokinetics
10. Insulin therapy
11. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus
12. Interval between insulin injection and eating in relation to blood glucose control in adult diabetics
13. Insulin administration
14. Timing of pre-meal insulins in diabetic patients on a multiple daily injection regimen. A questionnaire study
15. Monomeric insulins obtained by protein engineering and their medical implications
16. Action Profile of the Rapid Acting Insulin Analogue: Human Insulin B28Asp
17. Insulin kinetic and -dynamic in diabetic patients under insulin pump therapy after injections of human insulin or the insulin analogue (B28Asp)
18. Comparison of the time-action profiles of U 40- and U 100-regular human insulin and the rapid-acting insulin analogue B28Asp
19. Time-action profile of the insulin analogue B28Asp
20. Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes mellitus
21. Improved glycemic control with insulin aspart: A multicenter randomized double-blind crossover trial in type 1 diabetic patients
22. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes
23. Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: A randomized controlled trial